Kamini Jakhar

Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model

Tripti Shrivastava, Balwant Singh, Zaigham Abbas Rizvi et al. · Frontiers in Immunology · 2021 · 28 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus

Praveenkumar Murugavelu, Reshma Perween, Tripti Shrivastava et al. · International Immunopharmacology · 2021 · 19 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections

Shailendra Mani, Anupamjeet Kaur, Kamini Jakhar et al. · International Journal of Biological Macromolecules · 2023 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant

Nitin Hingankar, Suprit Deshpande, Payel Das et al. · PLoS Pathogens · 2022 · 14 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41

Reshma Perween, Praveenkumar Murugavelu, Tripti Shrivastava et al. · International Immunopharmacology · 2021 · 13 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14